GlassScriptPhysician profile
Sarah Renee Mobbs
NPI 1811401854
$11,728.15
in general payments reported to CMS, 2019-2025
45 companies · $3,458 in 2025
The $3,458 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,234 · 2022: $885 · 2023: $2,460 · 2024: $3,690 · 2025: $3,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,550 · Travel and Lodging: $780 · Education: $181 · Grant: $79.99 · Consulting Fee: $18.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,549.55 |
| Travel and Lodging | $779.86 |
| Education | $180.85 |
| Grant | $79.99 |
| Consulting Fee | $18.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,741.24 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,607.43 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,403.94 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Regeneron Healthcare Solutions, INC. | $939.79 | 2021-2025 | Dupixent |
| Grifols USA, LLC | $900.56 | 2021-2025 | Xembify, Prolastin-C Liquid |
| Genzyme Corporation | $639.46 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $591.18 | 2021-2025 | Acthar, Terlivaz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $489.07 | 2021-2025 | Ofev, Jascayd |
| Amgen INC. | $414.15 | 2021-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $315.46 | 2022-2025 | Opsumit, Uptravi, Opsynvi |
| Takeda Pharmaceuticals U.S.A., INC. | $238.14 | 2021-2025 | Cuvitru, Glassia |
| Merck Sharp & Dohme LLC | $177.01 | 2024-2025 | Winrevair |
| Viatris Specialty LLC | $167.86 | 2025 | Yupelri |
| Insmed, INC. | $161.37 | 2023-2024 | Arikayce |
| Abbvie INC. | $147.96 | 2021-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $145.60 | 2024-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Electromed, INC. | $135.10 | 2022-2024 | Smartvest |
| Alexion Pharmaceuticals, INC. | $123.13 | 2021-2023 | Ultomiris |
| Verona Pharma, INC. | $120.59 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $119.21 | 2021-2025 | |
| Baxter Healthcare | $117.33 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Bayer Healthcare Pharmaceuticals INC. | $106.04 | 2021-2024 | |
| Philips North America LLC | $80.17 | 2023-2025 | Vest Therapy Und |
| Axsome Therapeutics, INC. | $74.67 | 2024-2025 | Sunosi |
| La Jolla Pharmaceutical Company | $73.47 | 2022-2025 | Giapreza |
| United Therapeutics Corporation | $72.36 | 2024-2025 | Tyvaso, Tyvaso |
| Pfizer INC. | $61.33 | 2024-2025 | |
| Octapharma USA, INC. | $61.30 | 2021 | |
| Csl Behring | $60.59 | 2023-2025 | Hizentra |
| Inogen, INC. | $51.55 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $51.32 | 2023 | Purified Cortrophin Gel |
| Abbott Laboratories | $43.54 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $34.35 | 2023-2024 | Lumryz |
| Jazz Pharmaceuticals INC. | $34.18 | 2025 | |
| Novartis Pharmaceuticals Corporation | $33.95 | 2024 | |
| Abiomed | $29.34 | 2025 | |
| Tactile Systems Technology INC | $28.77 | 2025 | Nimbl, Flexitouch Plus |
| Seqirus USA INC | $24.64 | 2025 | Fluad, Flucelvax |
| Sanofi Pasteur INC. | $20.59 | 2025 | |
| Adma Biomanufacturing LLC | $18.46 | 2024 | |
| Mylan Specialty L.P. | $17.61 | 2024 | Yupelri |
| Paratek Pharmaceuticals, INC. | $17.49 | 2025 | Nuzyra |
| Vifor Pharma, INC. | $13.76 | 2024 | Zemaira |
| Exthera Medical Corporation | $11.92 | 2021 | |
| Gilead Sciences, INC. | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Mobbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.